Media Library
icon
-
ImagelockLeadership / ImagePatrice Bula
Board member since 2019 | Lead Independent Director since 2022 -
ImagelockManufacturing / ImageOperator Labels Culture Plates
A process operator labels culture plates for environmental monitoring. Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. -
ImagelockManufacturing / ImageOperator Prepares Connecting Hose
A process operator prepares connecting hose for later use in production process. Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. -
ImagelockManufacturing / ImageOperators in a clean room
Process operators in a clean room. Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. -
ImagelockManufacturing / ImageNovartis Site in Stein, Switzerland
Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. -
ImagelockManufacturing / ImageOperator with Culture Medium Bag
A process operator with culture medium bag. Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. -
ImagelockLocations / ImageBad Säckingen Novartis Stein, Switzerland
Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. -
ImagelockLeadership / ImageSimon Moroney, D.Phil.
Board member since 2020 | Vice-Chair since 2022 -
ImagelockLeadership / ImageBridgette Heller
Board member since 2020 -
ImagelockLeadership / ImageLutz Hegemann, M.D., Ph.D.
President, Global Health and Swiss Country Affairs -
VideolockManufacturing / VideoManufacturing CAR-T Cell Therapies: The Novartis Approach
Novartis has created a sophisticated process for manufacturing CAR T Cell Therapies. Novartis CAR-T Cell theapy is developed using the patient's own T-Cells which are part of the body immune system and play a central role in fighting disease. -
VideolockScience & Innovation / VideoThe science behind CAR-T cell therapy
An animated overview of the science behind CAR-T cell therapy.